Seres Therapeutics, Inc. ($MCRB)
Henn Matthew R โ Chief Scientific Officer and EVP
Shares
98
Price
$0.00
Total Value
$0.00
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Henn Matthew R |
|---|---|
| Title | Chief Scientific Officer and EVP |
| Transaction Date | Feb 15, 2026 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Disposed |
| Security | Restricted Stock Units |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Feb 18, 2026 |
| Document Date | Feb 15, 2026 |
| Shares Purchased | 98 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 780 |
| Derivative | Derivative |
| Accession Number | 0001193125-26-057153 |
| Document | View SEC Filing |